During the past decade, University Clinical Center Tuzla conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Clinical Center Tuzla" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Aileron Therapeutics, Inc." with 1 trials sponsored, "Celgene" with 1 trials sponsored, "Immunic AG" with 1 trials sponsored and "Mabion SA" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Clinical Center Tuzla" #1 collaborator was "University Clinical Center Tuzla" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University Clinical Center Tuzla" are "Appendicitis" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Early Breast Cancer" (1 trials), "Low-Grade Squamous Intraepithelial Lesions" (1 trials) and "Multiple Sclerosis" (1 trials). Many other conditions were trialed in "University Clinical Center Tuzla" in a lesser frequency.

Most popular intervention types in "University Clinical Center Tuzla" are "Drug" (9 trials), "Biological" (1 trials), "Device" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Interferon beta-1a" (2 trials), "ALRN-6924" (1 trials), "Adalimumab with methotrexate" (1 trials), "Cyclophosphamide" (1 trials) and "DL-alpha lipoic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Clinical Center Tuzla" are 10 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University Clinical Center Tuzla". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in University Clinical Center Tuzla, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University Clinical Center Tuzla, 1 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".

University Clinical Center Tuzla has several departments that took part in Clinical trials: "University Clinical Center Tuzla, Clinic for Oncology, Hematology and Radiotherapy" - 2 trials